Geistlich

Geistlich company information, Employees & Contact Information

Explore related pages

Related company profiles:

Geistlich is a global leader dedicated to advancing regenerative medicine. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, Geistlich is committed to providing comprehensive support to clinicians in the field of regenerative medicine through scientific research, innovative developments as well as educational programs. Geistlich is a Swiss family-owned company with tradition since 1851. With 15 subsidiaries and 60 distributors, the company reaches around 90 markets and employs over 800 people. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas

Company Details

Employees
453
Address
D4 Business Village Luzern, Root Längenbold,luzern 6039,switzerland
Phone
(855) 799-5500
Email
in****@****-na.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Root Längenbold, Luzern
Looking for a particular Geistlich employee's phone or email?

Geistlich Questions

News

Geistlich Announces Exclusive Distribution Partnership for its Leading Wound Care Portfolio in the United States - Business Wire

Geistlich Announces Exclusive Distribution Partnership for its Leading Wound Care Portfolio in the United States Business Wire

Geistlich unveils vallos™ - a new demineralized allograft that sets the pace for regeneration - PR Newswire

Geistlich unveils vallos™ - a new demineralized allograft that sets the pace for regeneration PR Newswire

Gabathuler becomes new CEO of Geistlich - Dental Tribune US

Gabathuler becomes new CEO of Geistlich Dental Tribune US

Geistlich Pharma North America Acquires Lynch Biologics - Dentistry Today

Geistlich Pharma North America Acquires Lynch Biologics Dentistry Today

New products: Geistlich launches 2 new collagen membranes - DrBicuspid.com

New products: Geistlich launches 2 new collagen membranes DrBicuspid.com

Geistlich announces the dramatic expansion of their allograft portfolio - vallos® sets the pace for regeneration - PR Newswire

Geistlich announces the dramatic expansion of their allograft portfolio - vallos® sets the pace for regeneration PR Newswire

Geistlich Immobilia ernennt Ladina Esslinger zur Geschäftsführerin - IMMOBILIEN Business

Geistlich Immobilia ernennt Ladina Esslinger zur Geschäftsführerin IMMOBILIEN Business

Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide® Articular Cartilage Cover - Business Wire

Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide® Articular Cartilage Cover Business Wire

Geistlich Pharma North America, Inc. Release: Geistlich Bio-Oss Portfolio Expands - BioSpace

Geistlich Pharma North America, Inc. Release: Geistlich Bio-Oss Portfolio Expands BioSpace

Full Availability of Geistlich Fibro-Gide®, The Alternative Soft-Tissue Graft - BioSpace

Full Availability of Geistlich Fibro-Gide®, The Alternative Soft-Tissue Graft BioSpace

Geistlich Pharma AG Executive Chairman, Dr. Andreas Geistlich, Honored with AAOMS Special Citation Award - PR Newswire

Geistlich Pharma AG Executive Chairman, Dr. Andreas Geistlich, Honored with AAOMS Special Citation Award PR Newswire

25 Year Follow up with Geistlich Bio-Oss Collagen® - PR Newswire

25 Year Follow up with Geistlich Bio-Oss Collagen® PR Newswire

StimLabs® Announces Exclusive Distribution Rights for Geistlich's Leading Wound Care Portfolio - PR Newswire

StimLabs® Announces Exclusive Distribution Rights for Geistlich's Leading Wound Care Portfolio PR Newswire

Geistlich Biomaterials Launches The Alternative Soft-Tissue Graft - PR Newswire

Geistlich Biomaterials Launches The Alternative Soft-Tissue Graft PR Newswire

Trust Us: Introducing The Geistlich Guarantee - PR Newswire

Trust Us: Introducing The Geistlich Guarantee PR Newswire

Geistlich Pharma North America, Inc. launches a complete line of Bone Harvesting Instruments - PR Newswire

Geistlich Pharma North America, Inc. launches a complete line of Bone Harvesting Instruments PR Newswire

HANSAmed Limited Introduces Geistlich Fibro-Gide®: The Alternative Soft-Tissue Graft - Oral Health Group

HANSAmed Limited Introduces Geistlich Fibro-Gide®: The Alternative Soft-Tissue Graft Oral Health Group

Geistlich dental products to be available in India - ET HealthWorld

Geistlich dental products to be available in India ET HealthWorld

Schlieren: Grundsteinlegung für Neubau auf dem Geistlich Areal - IMMOBILIEN Business

Schlieren: Grundsteinlegung für Neubau auf dem Geistlich Areal IMMOBILIEN Business

Geistlich Pharma AG Acquires Minority Stake in TRI Dental Implants Int. AG - Global Legal Chronicle

Geistlich Pharma AG Acquires Minority Stake in TRI Dental Implants Int. AG Global Legal Chronicle

Top Geistlich Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant